NO | ຜະລິດຕະພັນ | cas no | ຕົວຊີ້ວັດທີ່ມີຄຸນນະພາບ | |||
ອັດຊາຍະ | ສູງສຸດທີ່ເຄຍ. ມະລະ | Restived Restivue | ຄວາມຊຸ່ມ | |||
1 | FMOC-β-Ala-Ala -h | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
2 | FMOC-D-Ala-D-Ala-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
3 | FMOC-β-Ala-D-Ala-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
4 | FMOC-Arg (PBF) -Ag (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
5 | FMOC-β-Ala-Arg (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
6 | FMOC-D-Arg (PBF) -D-Arg (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
7 | FMOC-β-Ala-D-Arg (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
8 | FMOC-HOMOARG (PBF) -HOMOARG (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
9 | FMOC-β-Ala-Homoarg (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
10 | FMOC-ASN (TRT) -ASN (TRT) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
11 | FMOC-β-ala-asn (trt) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
12 | FMOC-ASP (OTBU) -ASP (OTBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
13 | FMOC-β-ala-asp (otbu) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
14 | fmoc-cys (trt) -cys (trt) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
15 | FMOC-β-ala-cys (trt) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
16 | fmoc-cys (ACM) -CSY (ACM) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
17 | FMOC-β-ala-cys (ACM) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
18 | fmoc-gln (trt) -gln (trt) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
19 | FMOC-β-ala-gln (trt) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
20 | FMOC-GLU (OTBU) -Glu (OTBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
21 | FMOC-β-ala-glu (otbu) -Oh.h2o | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
22 | FMOC-β-ala-gly-oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
23 | FMOC- ຂອງລາວ (trt) -his (trt) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
24 | FMOC-β-ala-his-his (trt) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
25 | FMOC-ILE-ILE-OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
26 | FMOC-β-Ala-ile-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
27 | FMOC-leu-leu-oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
28 | FMOC-β-ala-leu-oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
29 | FMOC-D-leu-d-leu-oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
30 | FMOC-β-Ala-D-Leu-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
31 | FMOC-LYS (BOC) -LYS (BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
32 | FMOC-β-ala-lys (boc) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
33 | FMOC-LYS (Alloc) -lys (Alloc) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
34 | FMOC-β-ala-lys (alloc) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
35 | met-met-met-ob | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
36 | fmoc-β-ala-met-oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
37 | FMOC-ONN (BOC) - ປະຕິບັດ -OH -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
38 | FMOC-β-ala-ornn (boc) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
39 | FMOC-PHE-PHE-OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
40 | FMOC-β-ala-phe-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
41 | FMOC-D-PHE-D-PHE-OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
42 | FMOC-β-Ala-D-Phe-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
43 | FMOC-Pro-Pro-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
44 | FMOC-β-ala-pro-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
45 | fmoc-ser (tbu) -ser (tbu) -Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
46 | FMOC-β-Ala-Ser (TBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
47 | fmoc-ser (trt)-trt) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
48 | FMOC-β-ala-ser (trt) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
49 | FMOC-THR (TBU) -HR (TBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
50 | FMOC-β-Ala-thr (TBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
51 | FMOC-TRP (BOC) -TRP (BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
52 | FMOC-β-Alp-TRP (BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
53 | FMOC-D-TRP (BOC) -D -D-TRP (BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
54 | FMOC-β-Ala-D-TRP (BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
55 | FMOC-TYR (TBU) -YR (TBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
56 | FMOC-β-Ala-Tyr (TBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
57 | FMOC-D-TYR (ET) -D -D-TYR (ET) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
58 | FMOC-β-Ala-D-TYR (ET) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
59 | fmoc-tyr (me) -tyr (ຂ້ອຍ) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
60 | FMOC-β-ala-tyr (ຂ້ອຍ) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
61 | fmoc-val-val-oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
62 | FMOC-β-Ala-Val-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
63 | FMOC-D-CIT-D-CIT-OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
64 | FMOC-β-ala-d-coun - ໂອ້ຍ | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
65 | FMOC-β-Ala-DAB-OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
66 | FMOC- (3- (2-naphthyl) -d-ac-ala) 2-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
67 | FMOC-β-Ala-3- (2-naphthyl) -d-ud-ala-ala-Oh-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
68 | FMOC- (3- (3-tyridinylyl) -D -La) 2-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
69 | FMOC-β-ala-3- (3-pyridinylyl) -D-Ala-Oh-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
70 | FMOC- (4-chloro-d-phe) 2-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
71 | FMOC-β-Ala-4-Chloro-D-PHE-OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
72 | FMOC- (D-4Aph (TBUCBM))) 2-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
73 | FMOC-β-Ala-D-4Aph (TBUCBM) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
74 | FMOC-APH (L-HOR) -Aph (l-hor) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
75 | FMOC-β-ala-aph (l-hor) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
76 | FMOC-LYS (IPR, BOC) -lys (IPR, BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
77 | FMOC-β-Ala-lys (IPR, BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
78 | FMOC-β-Ala-AEEAO-OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
79 | FMOC-AIB-AIB-OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
80 | FMOC-β-Ala-Aib-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
81 | FMOC-Arg-Oh | 91000-69-0 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
82 | H-Arg (PBF) -OH | 200115-86-2 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
83 | FMOC-D-Arg-Oh | 130752-32-8 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
84 | HD-Arg (PBF) -OH | 200116-81-0 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
85 | FMOC-HOMOARG-OH.HCL | 208174-14-5 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
86 | H-homoarg (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
87 | FMOC-D-HOMOARG-OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
88 | HD-HOMOARG (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
89 | fmoc-asn-oh | 71989-16-7 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
90 | h-asn (trt) -OH | 132388-58-0 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
91 | FMOC-ASP-OH | 119062-05-4 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
92 | h-asp (otbu) -Oh | 3057-74-7 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
93 | FMOC-CYS-OH | 135248-89-4 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
94 | H-cys (trt) -OH | 2799/7/7 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
95 | h-cys (ACM) -Oh.hcl | 28798-28-9 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
96 | FMOC-GLN-OH | 71989-20-3 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
97 | H-gln (trt) -OH | 102747-84-2 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
98 | FMOC-GLU-OH | 121343-82-6 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
99 | H-glu (otbu) -Oh.h2o | 2419-56-9 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
ຮ້ອຍ | FMOC- ຂອງລາວ - ໂອ້ຍ | 116611-64-4 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
101 | h-his (trt) -OH | 35146-32-8 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
ມັດສະລອນ 102 | BOC-YO-OH | 17791-52-5 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
103 | fmoc-lys-oh | 105047-45-8 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
ມີ 104 | H-lys (BOC) -OH | 2418-95-3 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
105 | h-lys (alloc) -Oh | 6298/3/9 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
106 | FMOC-ONN-OH. Oh.HCL | ປີ 2010-57-3 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
107 | H-orn (BOC) -OH | 13650-49-2 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
ມັດຖິຄະ | fmoc-ser-oh | 73724-45-5 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
109 | H-SE (TBU) -OH | 18822-58-7 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
110 | h-ser (trt) -Oh | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
111 | FMOC-THR-OH.H2O | 73731-37-0 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
112 | h-thr (tbu) -Oh | 4378-13-6 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
113 | FMOC-TRP-OH | 35737-15-6 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
114 | H-TRP (BOC) -OH | 146645-63-8 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
115 | FMOC-D-TRP-OH | 86123-11-7 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
116 | HD-TRP (BOC) -OH | ປີ 201290-11-1 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
ຕຸລາຫານ | fmoc-tyr-oh | 92954-90-0 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
ຕຸລາ | h-tyr (tbu) -Oh | 18822-59-8 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
ສິບສາມ | FMOC-D-TYR-OH | 112883-29-1 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
ສິບສາມ | HD-TYR (ET) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
121 | h-tyr (ຂ້ອຍ) -Oh.hcl | 67423-44-3 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
ສິບສາມ2 | FMOC-D-4AP (CBM) -OH | 324017-22-3 | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
123 | HD-4Aph (TBUCBM) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
124 | FMOC-LYS (IPR) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
125 | H-lys (IPR, BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0.0% | ≤2.0% |
ການຊົດເຊີຍ
Gentolex ສະເຫນີຜະລິດຕະພັນທີ່ມີຄຸນນະພາບດີ, ຖ້າມີຄຸນນະພາບຂອງຜະລິດຕະພັນພາຍໃນເວລາທີ່ຈໍາເປັນ, ພວກເຮົາຈະໃຫ້ການວິເຄາະແລະການປະເມີນຜົນທີ່ຈໍາເປັນເພື່ອເຮັດໃຫ້ຂັ້ນຕອນການຊົດເຊີຍ.
ການຜະລິດ
ຄວາມສາມາດຂອງຜະລິດຕະພັນຢາບັນລຸໄດ້ຄະແນນໂຕນໄດ້ຮັບການຈັດອັນດັບເປັນປະຈໍາ, ຄວາມສາມາດຂອງຜະລິດຕະພັນສານເຄມີສາມາດບັນລຸໄດ້ 100tons + ຊັ້ນ, ແມ່ນມີຄວາມພ້ອມດີໃນການຮັບໃຊ້ລູກຄ້າທົ່ວໂລກ.
ການຄົ້ນຄວ້າແລະການພັດທະນາ
ໃນແຕ່ລະປີ, ມີແຜນການສ້າງແຜນການຂອງ R & D ເພື່ອພັດທະນາຜະລິດຕະພັນໃຫມ່ທີ່ແຕກຕ່າງກັນ, ເມື່ອກໍານົດເປົ້າຫມາຍ, ສະມາຊິກທຸກຄົນຈະຕ້ອງໄດ້ຮັບຄວາມຮັບຜິດຊອບຂອງ KPI ແລະດ້ວຍນະໂຍບາຍທີ່ມີແຮງຈູງໃຈ.